Atlanta Dental Supply Co. Set to Release Revolutionary New fiteBac SkinCare Products at National Dental Show

Share Article

fiteBac™SkinCare, LLC, a subsidiary of Kimmerling Holdings Group, located in Marietta, GA, has released its products to Atlanta Dental Supply Co. for distribution. Atlanta Dental will formally launch the products at the annual Hinman Dental Meeting in Atlanta, GA. This launch, along with a favorable report by Dr. John Molinari of THE DENTAL ADVISOR, will propel fiteBac SkinCare into national recognition.

Atlanta Dental Supply Sell New Technology in Hand Sanitizing

Atlanta Dental Supply Introduces fiteBac SkinCare Germicial Hand Softening Gel

The purpose of fiteBac products is to encourage hand hygiene compliance among dental and medical personnel in order to create a safer, healthier environment for both professionals and patients.

fiteBac™SkinCare, LLC, is about to become a celebrated name among medical and dental personnel. The Atlanta Dental Supply Company will formally launch fiteBac’s revolutionary new Germicidal Hand Softening Gel at the upcoming 100th Annual Thomas P. Hinman Dental Meeting, which will take place at the Georgia World Congress Center in Atlanta from Thursday, March 22 through Saturday, March 24. Dental professionals from around the world will attend the Hinman Meeting to enjoy hands-on courses, exciting programs, and special events, such as a visit to the New Product Pavilion, where fiteBac Germicidal Gel will be on display.

Sixty-five leading authorities in dentistry will speak at this year’s Hinman Meeting, including Dr. John A. Molinari, Director of Infection Control of THE DENTAL ADVISOR. Dr. Molinari will teach three courses under the topics of Infection Control, Infectious Disease, and Allergies. His expertise and experience in these fields led him to study the antimicrobial functions of the fiteBac Germicidal Hand Gel. His report demonstrated favorable findings with fiteBac’s product. Other renowned scientists and researchers are currently studying the unique technology behind the fiteBac product for other applications.

In addition to the unique germ-fighting properties that fiteBac Germicidal Hand Gel possesses, the product is also alcohol-free, so it will not dry out or irritate the skin. The fiteBac gel leaves hands feeling soft and moisturized. Atlanta Dental will have the product available for general distribution beginning March 2012. 

The purpose of fiteBac products is to encourage hand hygiene compliance among dental and medical personnel in order to create a safer, healthier environment for both professionals and patients. After the official  launch at the Hinman Dental Meeting, fiteBac expects to receive national recognition among dental and medical professionals. fiteBac looks forward to its new relationship with Atlanta Dental and to the forthcoming connections that will be made at the Hinman Meeting.

About fiteBac™SkinCare, LLC and KHG: fiteBac SkinCare, LLC is a subsidiary company of Kimmerling Holdings Group, LLC (“KHG”), a Georgia-based biotech company that has developed an antimicrobial platform intellectual property technology. KHG was founded in 2009 by Kirk Kimmerling, DDS Marietta Dentist, and Dan Kearney. The two set out to create products to “change the world, one product at a time.” Kirk and Dan first targeted bacterial issues in dentistry, knowing that solving those problems would lead to dramatic improvements in oral health, and more importantly, systemic bodily health. They engaged a team of highly accomplished chemists and scientists retired from Fortune 500 companies and researchers from major universities. In doing so, KHG has developed technology with several patents pending that has application well beyond dental materials, and has exciting potential in medical, plastic, composite, coating and other applications that are in various stages of development, some close to commercialization. fiteBac SkinCare Hand Softening Gel is the first product to be released under the fiteBac brand name.

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Kirk Kimmerling, President & CEO
Visit website